The diverse receptor-ligand pairs of the Wnt and frizzled (Fz) families play important roles during embryonic development, and thus may be overexpressed in cancers that arise from immature cells. Hence, we investigated the expression and function of five Wnt (Wnt-1, 5a, 7a, 10b, 13) and two Fz (Fz-2, 5) genes in 10 head and neck squamous carcinoma cell lines (HNSCC). In comparison to normal bronchial or oral epithelial cells, all the HNSCC had markedly increased mRNA levels of Wnt-1, 7a, 10b, and 13, as well as Fz-2. Moreover, the levels of Wnt-1, 10b, and Fz-2 proteins were also markedly increased in HNSCC, relative to normal epithelial cells. Treatment of one HNSCC cell line (SNU 1076) with anti-Wnt-1 antibodies reduced the activity of the Wnt/Fz dependent transcription factor LEF/TCF, and diminished the expression of cyclin D1 and b-catenin proteins. Blocking Wnt-1 signaling also inhibited proliferation and induced apoptosis in these cells. These results show that HNSCC cell lines often overexpress one or more Wnt and Fz genes, and suggest that the growth and survival of a subset of HNSCC may depend on the Wnt/Fz pathway. Hence, the Wnt and Fz receptors may be possible targets for immunotherapy therapy of this common cancer.
Introduction
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer in developed countries, and of the 44 000 annual cases reported in the United States approximately 11 000 will result in an unfavorable outcome (Landis et al., 1999; Parkin et al., 1999) .
Although metastatic HNSCC can respond to chemotherapy and radiotherapy, it is seldom adequately controlled. Therefore, it is important to identify new molecular determinants on HNSCC that may be potential targets for chemotherapy or immunotherapy.
In the past decade there has been tremendous progress in identifying genetic and molecular changes that occur during the transformation of malignant cells. Many malignant cells have a less differentiated phenotype, and a higher growth fraction than normal adult tissues. These basic characteristics are similar to immature or embryonic cells. During the development of the embryo, various cell surface receptors and ligands direct tissue pattern formation, and cellular differentiation (Hunter, 1997; Ng et al., 1999; Ramsdell and Yost, 1998) . The expression of these receptors and ligands is often no longer required in fully matured adult tissues. Because they are expressed on the cell surface, the receptors and ligands important for morphologic patterning and tissue differentiation could be targets for the immunotherapy of tumors that have arisen from residual immature cells, or that have undergone de-differentiation.
Genes of the wingless (Wnt) and frizzled (Fz) class have an established role in cell morphogenesis and cellular differentiation (Parr et al., 1993; Riddle et al., 1995; Vogel et al., 1995) . The Wnt genes encode a family of 38 -45 kDa secreted cysteine-rich proteins that lack transmembrane domains and are modified by N-linked glycosylation. The secreted Wnts associate with extracellular matrix proteins on or near the cell surface, and thus can exert autocrine or paracrine effects. The Wnt proteins are ligands for the Fz receptors, which resemble typical G protein coupled receptors. The first member of the 19 known human Wnt genes, Wnt-1, was initially discovered because of its oncogenic properties (Nusse and Varmus, 1982) . Signaling downstream of some Fz homologs, in response to Wnt-1 or other transforming Wnts, leads to activation of the phosphoprotein Dishevelled (Dsh), which inhibits the ability of glycogen synthase kinase3b to phosphorylate b-catenin. Whereas phosphorylated b-catenin is unstable and degraded rapidly, the unphosphorylated protein accumulates in the cytosol, and nucleus, where it binds to members of the TCF/ LEF transcription factor family (Cadigan and Nusse, 1997; Miller et al., 1999) . These transcription factor complexes control the activities of specific Wnt target genes, including developmental regulators and other genes involved in co-ordinating cell proliferation, such as cyclin D1, c-myc and fibronectin. The overexpression of b-catenin and LEF-1 has been demonstrated to result in the oncogenic transformation of chicken fibroblasts (Aoki et al., 1999) .
A recent survey using microarray techniques showed that most HNSCC overexpress mRNAs of the Wnt family (Leethanakul et al., 2000) . However, the various Wnt mRNAs are very homologous, and hybridization in microarrays often cannot distinguish between closely related templates. Also, it is not known if Wnt and Fz proteins are expressed in HNSCC cells, and if they play any role in cell growth and survival.
The hypothesis that prompted this study was that different clonal populations of HNSCC might overexpress various receptors of the Wnt and Fz family, because of their immature cell of origin, and the growth and survival advantage provided by autocrine or paracrine Wnt/Fz signaling. We examined HNSCC and normal human epithelial cell lines for the expression of five Wnt and two Fz genes. The results showed that most HNSCCs did indeed overexpress one or more Wnt and Fz mRNAs. Moreover, the Wnt/Fz pathway was functional in some of the HNSCC cells, as indicated by the constitutive expression of a LEF/ TCF reporter gene. In the SNU 1076 cell line, antiWnt-1 or anti-Wnt-10b antibodies decreased the expression of b-catenin and cyclin D1, inhibited cell growth, and induced apoptosis. Thus, the Wnt and Fz genes are frequently overexpressed in HNSCC, and might be attractive targets for both immunotherapy and drug therapy.
Results

Expression of Wnt and Fz mRNAs in HNSCC
Ten different HNSCC cell lines, two normal human broncho-epithelial (NHBE) cell lines, and normal oral squamous epithelial cells were tested by RT -PCR for the expression of five Wnts (Wnt-1, Wnt-5a, Wnt-7a, Wnt-10b, Wnt-13), and two Fzs (Fz-2 and 5). Representative results are illustrated in Figure 1 and are summarized in Table 1 . When compared to the housekeeping gene G3PDH, all the Wnts, as well as Fz-2, were expressed more frequently in HNSCC than in normal cells, while there was no difference in Fz-5 gene expression. Of the Wnt genes, Wnt-1, 5a, and 10b were most strongly expressed by the malignant cells, but were barely detectable in the normal tissues tested. Real time PCR assays, confirmed that the gene expression levels of Wnt-1 were 17-fold higher, and Wnt-10b was threefold higher in the SNU1076 HNSCC cells than in the normal Detroit 551 cells. Subsequently, we focused on Wnt-1 and Wnt-10b, since these Wnts signal through the canonical bcatenin and LEF/TCF pathway, and because affinity purified antibodies to the extracellular domains were available. 
Effects of anti-Wnt antibodies and SFRP1
Treatment with antibody against Wnt-1 or Wnt-10b decreased the proliferation of the SNU1076 HNSCC cell line (Figure 3 ), while little effect was observed in PCI 13 cells (data not shown). The inhibition of cell growth by the antibodies was dependent on the concentration and incubation time. The treatment of the SNU1076 HNSCC cell line with anti-Wnt antibodies, but not control antibody, also induced apoptosis ( Figure 4 ). Similar to anti-Wnt antibodies, treatment with recombinant secreted frizzled related protein 1 (SFRP1) (2 mg/ml), a natural antagonist of Wnt signaling, inhibited growth of SNU 1076 cells ( Figure 5 ), but not Detroit 562 (not shown).
To determine if the effects of anti-Wnt antibody on SNU1076 cells were related to inhibition of Wnt signaling, we compared levels of the Wnt regulated genes cyclin D1 and fibronectin ( Figure 6a ). The antiWnt-1 antibody, but not the control IgG, reduced cyclin D1, fibronectin, and b-catenin levels in the lysate of SNU 1076 cells. To confirm these results, TOPFLASH-Luc, a reporter plasmid containing TCF/LEF binding sites, or FOPFLASH-Luc, a negative control plasmid having mutant binding sites was introduced into SNU 1076 cells together with the pCMV-b-gal plasmid (to assess transfection efficiency). Luciferase activity was higher in the TOPFLASH than the FOPFLASH transfected cells, indicating that LEF/ TCF dependent transcription was constitutively active. Cells transfected with FOPFLASH showed no changes in the low baseline luciferase activity after treatment with anti-Wnt-1 antibodies, whereas cells transfected with TOPFLASH displayed decreased luciferase activity ( Figure 6b ).
Discussion
To evaluate Wnt and Fz receptors as potential tumor associated antigens in head and neck squamous cell cancers (HNSCC), we screened various tumor and normal cell lines by both RT -PCR, and immunoblotting. The results revealed that Wnt-1, Wnt-10b, Wnt-13, and Fz-2 were overexpressed in many HNSCC cells, compared to normal human bronchoepithelial (NHBE) cells. The amino acid sequence of Fz-2 is very homologous to Fz-1 and 7 (Sagara et al., 1998) . However, we confirmed that the Fz-2 gene was specifically amplified in the tumor lines by cloning and sequencing the RT -PCR products. In addition, immunoblotting showed reduced Fz-2 protein in the lysates of NHBE in which there were weakly detectable or undetectable products by RT -PCR. The human Fz-2 gene originally was isolated by Sagara et al. (1998) . These investigators also found that the mRNA for Fz-2 was not detectable in any of 15 different normal human adult tissues, with the possible exception of Normal fibroblasts, a colon cancer line and a HNSCC line were lysed in buffer containing 1% digitonin and the soluble phase isolated. These samples were separated by SDS -PAGE, blotted onto PDVF membranes and successively probed with the indicated antibodies. The membranes were developed using a chemiluminescence system (ECL detection reagent: Amersham Life Science, Aylesbury, UK), and scanned with a laser densitometer. The density relative to the actin band is given beneath each band heart. In contrast, embryonic tissues, as well as six of eight malignant cell lines, expressed abundant Fz-2 mRNA. However, according to the most recent SOURCE gene report (http://genome-www5. stanford.edu), Fz-2 mRNA is widely expressed in the adult. Our studies show that Fz-2 protein expression is prominent in HNSCC cell lines, when compared to normal NHBE cells. Hence, antibodies against specific determinants of the extracellular domain of Fz-2 might preferentially bind to and target such malignant cells.
Compared to NHBE cells, the HNSCC cell lines expressed much higher message levels of Wnt-1, Wnt10b and Wnt-13. Immunoblotting experiments confirmed the overexpression of Wnt-1 and Wnt-10b protein in several HNSCC cell lines. Since the tumors had high levels of both the ligands and their Fz-2 receptors, it was important to determine if Wnt/Fz signaling was constitutively active in the HNSCC cells. The canonical Wnt/Fz signaling cascade leads to the accumulation of cytoplasmic b-catenin and its translocation to the nucleus. In the nucleus b-catenin binds a specific sequence motif at the N-terminus of lymphoidenhancing factor/T cell factor (LEF/TCF) to generate a transcriptionally active complex (Behrens et al., 1996) . Experiments using a LEF/TCF reporter gene, TOPFLASH, demonstrated that LEF/TCF dependent transcription was active in the SNU 1076 cells.
Although Wnt and Fz were expressed in HNSCC cells, they could be dispensable for cell growth and survival. To test this possibility, the effects of antibodies to the extracellular domains of Wnt-1 and Wnt-10b were studied in three HNSCC lines known to express the receptors. When compared to control antibodies, both anti-Wnt antibodies slowed the growth of one of three HNSCC cell lines (SNU 1076) and resulted in apoptosis. Treatment with high levels of SFRP1, a Wnt antagonist, also inhibited the growth of SNU1076 cells. Moreover, interference with Wnt/ frizzled signaling in SNU 1076 cells decreased the activity of the LEF/TCF reporter gene, and reduced levels of b-catenin cyclin D1 and fibronectin. These results suggest that continued autocrine or paracrine Wnt/Fz signaling may be required for the growth and survival of a subset of HNSCC cells.
Not all HNSCC cell lines that overexpressed Wnt-1 or Wnt-10 were sensitive to the growth inhibitory effects of blocking antibodies against the Wnts, or to SFRP protein. The activation of b-catenin dependent genes in the resistant cells may depend on signaling through integrin-linked kinases and other Wnt-independent pathways (Yoganathan et al., 2000) . If Wnt-Fz signaling requires cell -cell or cell -matrix contact, the repeated passage of HNSCC cell lines at low density would select for Wnt-independent variants. In this regard, it is notable that the anti-Wnt sensitive SNU 1076 cell line was only recently established in culture (Ku et al., 1999) . Future experiments should examine the effects of Wnt and Fz antagonists on colony formation by primary HNSCC cells.
The results of our experiments suggest that antibodies against Wnt family members may exert two different effects in HNSCC cancers in vivo. In malignant cells that depend on Wnt/Fz signaling for survival, the antibodies might directly slow tumor growth and/or induce apoptosis. In HNSCC cells that incidentally overexpress the receptors, but do not require them for proliferation, the antibodies still could potentially target the tumor cells for killing by complement, or antibody dependent cellular toxicity. Based on these data, we suggest that passive immunotherapy could be a useful adjunctive therapy in HNSCC that overexpress one or more Wnt and Fz receptors.
Materials and methods
Cell lines and culture
Ten HNSCC, two B lymphoma, and two glioblastoma cell lines were studied. Detroit-562 (pharyngeal cancer), KB (carcinoma in the floor of the mouth), RPMI-2650 (nasal septal cancer), SCC-25 (tongue cancer), U87MG and U373MG (glioblastoma), Ramos (lymphoma), Detroit-551 (human skin fibroblast-like cells), SW620 (colon cancer) and WI-38 (human lung fibroblasts) were purchased from the American Type Culture Collection (Manassas, VA, USA). The PCI-1, 13, and 50 cell lines were kindly provided by Dr T Whiteside (University of Pittsburgh, PA, USA) (Whiteside et al., 1998; Yasumura et al., 1993) . The HNSCC cell lines SNU 1066, SNU 1076 and AMC 4 cell lines were provided by Dr JG Park (Seoul National University, Korea) and Dr Figure 4 Apoptotic effect of inhibition of the Wnt/Frizzled signaling pathway in a HNSCC line. SNU1076 was treated for 72 h with 2 mg/ml of anti-Wnt-1, Wnt-10b, or control antibodies. The cytotoxic effects of these antibodies were assessed by vital dye retention and DNA content. Cells were detached from the flasks by trypsin treatment and incubated for 10 min in growing medium with 5 mg/ml Propidium iodide (PI) and 40 nM DiOC 6 and analysed by flow cytometry. Viable cells had high DiOC 6 (FL-1) and low PI (FL-3) fluorescence, and apoptotic cells had low DiOC 6 (FL-1) and low PI (FL-3) fluorescence SY Kim (University of Ulsan, Korea), respectively (Ku et al., 1999; Kim et al., 1997) . Two different normal human tracheobronchial epithelial (NHBE) cells derived from different persons were purchased from Clonetics (San Diego, CA, USA). All cancer cell lines were cultured at 378C in a humidified atmosphere of 5% CO 2 , in either RPMI 1640, DMEM (Dulbecco's modified Eagle's medium), or Ham's 12-DMEM medium, as recommended by the suppliers, supplemented with 10% fetal bovine serum. NHBE cells were cultured in the bronchial epithelial cell growth media provided by the company. Normal epithelial cells were obtained from scrapings of the oral mucosa of 10 normal healthy volunteers. All cell lines were found to be free of mycoplasma contamination.
RT -PCR analyses
Total RNA was extracted by using Trizol 1 (Gibco -BRL, Grand Island, NY, USA), according to the manufacturer's directions. Different pairs of gene-specific primers based on GenBank sequences of cloned human Wnt and Fz genes were used for reverse transcriptase-PCR (RT -PCR) analysis. Reverse transcription was performed with a Superscript TM Preamplification kit (Gibco -BRL). One microgram of RNA was used from each sample. For Wnt 1, Wnt 5a, Wnt 13, Wnt 10b, Fz 5 and GAPDH 30 cycles of PCR were used, and for Wnt 7a and Fz 2 25 cycles were used. The PCR products were separated by electrophoresis, visualized under ultra violet light, and scanned with a laser densitometer. The intensities of the Wnt and Fz bands were compared with the amplicon of the housekeeping gene G3PDH. Preliminary experiments confirmed that the PCR amplifications had not reached a plateau for all data reported in the results. The following list summarizes the primer pairs used: Fz-2 : 5'-CAGCGTCTTGCCCGACCAGATCCA-3' (reverse); 5'-CT-AGCGCCGCTCTTCGTGTACCTG-3' (forward). Fz-5 : 5'-TTCATGTGCCTGGTGGTGGGC-3' (forward); 5'-TACA-CGTGCGACAGGGACACC-3' (reverse). Wnt-1 : 5'-CACG-ACCTCGTCTACTTCGAC-3' (forward); 5'-ACAGACACT-CGTGCAGTACGC-3' (reverse). Wnt-5a: 5'-ACACCTCT-TTCCAAACAGGCC-3' (forward); 5'-GGATTGTTAAACT-CAACTCTC-3' (reverse) Wnt-7a: 5'-CGCAACAAGCGGC-CCACCTTC-3' (forward), 5'-TCCGTGCGCTCGCTGCA-CGTG-3' (reverse) Wnt-10b: 5'-GAATGCGAATCCACAA-CAACAG-3' (forward); 5'-TTGCGGTTGTGGGTATCAA-TGAA-3' (reverse). Wnt-13 : 5'-AAGATGGTGCCAACTT-CACCG-3' (forward); 5'-CTGCCTTCTTGGGGGCTTT-GC-3' (reverse) G3PDH: 5'-ACCACAGTCCATGCCAT-CAC-3' (forward); 5'-TACAGCAACAGGGTGGTGGA-3' (reverse). The specificities of the Wnt and Fz PCR products were confirmed by cloning and sequencing the products, using a TOPO TA Cloning kit and M13 primers (Invitrogen, Carlsbad, CA, USA).
In addition, the mRNA levels were quantified by real time RT -PCR on the ABI Prism 7700 Sequence detection system (Applied Biosystems, Foster City, CA, USA) using the following primer sets: Wnt-1 forward 5'-CGAACCTGCTTA-CAGACTCCA-3', reverse 5'-CAGACGCCGCTGTTTGC-3' and probe 5'-TGCAACTGGTACTCGAGCCCAGTCTG-3', Wnt-10b forward 5'-CCTCGCGGGTCTCCTGTT-3', reverse 5'-AGGCCCAGAATCTCATTGCTTA-3' and probe 5'-CTGGCGTTGTGCAGTCGGGCT-3'. PCR was performed using Taqman PCR Core Reagents (Applied Biosystems, Foster City, CA, USA) according to the manufacturers instructions. PCR cycles consisted of an initial desaturation step at 958C for 15 s and at 608C for 60 s. PCR amplification of 18S RNA was done for each sample as a control of sample loading and to allow for normalization between samples. A standard curve was performed by serial dilution of a single batch of RNA from tumor cells previously demonstrated to express the mRNA to be tested. The relative message levels Figure 6 (a) Immunoblot after treatment with Wnt-1 or Wnt-10b antibodies. SNU 1076 cells were treated for 72 h with 2 mg/ml of anti-Wnt 1, Wnt-10b, or control antibodies. Twenty mg of protein from each cell line was separated by SDS -PAGE and transferred to a PVDF membrane. The membrane was immersed in 2% Iblock, 0.05% Tween X in PBS and then incubated with a monoclonal anti-human b-catenin, cyclin D1, or fibronectin IgG. These primary antibodies were then detected by horseradish peroxidaseconjugated anti-IgG and chemiluminescence. To verify and compare relative amounts of protein in each lane, the PVDF membrane was stripped with Re-Blot TM Western blot recycling kit and reprobed for other antibodies including anti-actin. (b) Treatment with Wnt-1 antibodies reduces transcription of TCF/LEF gene. SNU 1076 cells were treated with 2 mg/ml of anti-Wnt-1, or control antibodies for 36 h. SNU 1076 cells were cotransfected with 0.5 mg/ ml of pTOPFLASH-Luc or pFOPFLASH-Luc and 0.5 mg/ml of pCMV-bGal. Cells were harvested 24 h after transfection, and lysed in lysis buffer. Luciferase and b-galactosidase activities determined using Dual-Light TM reporter gene assay system. Luciferase activities of each of pTOPFLASH-Luc or pFOPFLASH-Luc and b-galactosidase activities of pCMV-bGal were measured in the same sample by luminometer. Transfection efficiency of each sample was normalized by the activity of b-galactosidase activity. Average absolute luciferase activity for pTOPFLASH-Luc and pCMVbGal cotransfected cells was 209628 for untreated cells, and 81386 for anti-Wnt-1 antibody treated cells with corresponding b-galactosidase activities of 206696 and 179259 units. Average absolute luciferase activity for pFOPFLASH-Luc and pCMV-bGal cotransfected cells was 7173 for untreated cells, and 5841 for anti-Wnt-1 antibody treated cells with corresponding b-galactosidase activities of 220038 and 194736 units were calculated relative to the standard calibration curve. Each sample was analysed in quadruplicate.
Immunoblotting
After removal of medium, cells in logarithmic growth were disrupted in lysis buffer (25 mM Tris HCl, 150 mM KCl, 5 mM EDTA, 1% NP-40, 0.5% sodium deoxycholic acid, 0.1% sodium dodecyl sulphate) including phosphatase and protease inhibitor cocktails. Alternatively in Figure 2c to release the cytosol the cells were lysed in HEB buffer (50 mM PIPES, 20 mM KCl, 5 mM EGTA, 2 mM MgCl 2 , 1 mM DTT, 0.1% digitonin, protease and phosphotase inhibitor cocktails and the soluble phase separated by centrifugation. Each lane of an SDS -PAGE gel was loaded with 20 mg of protein.
After electrophoresis, the proteins were transferred to a polyvinylidene difluoride (PVDF) membrane, blocked with 2% I-block TM (Tropix Inc, Bedford, MA, USA) containing 0.05% Tween-X in PBS, and then incubated with primary antibody. Horseradish peroxidase-conjugated anti-IgG (Santa Cruz Laboratories, Santa Cruz, CA, USA) was used as the secondary antibody. The membranes were developed using a chemiluminescence system (ECL detection reagent: Amersham Life Science, Aylesbury, UK), and scanned with a laser densitometer. The membranes were stripped with Re-Blot TM Western blot recycling kit (Chemicon International Inc, Temecula, CA, USA) and reprobed using other antibodies and actin monoclonal antibody (Chemicon International Inc) as a control. Prestained molecular weight markers (New England Biolabs, Beverly, MA, USA) were used as reference.
Antibodies
Peptide affinity purified polyclonal antibodies specific for the amino terminal extracellular domains of Wnt-1 (A-20) and , and for the carboxy terminal region of Fz-2, were purchased from Santa Cruz Laboratories, and monoclonal antibodies specific for b-catenin and fibronectin were purchased from Transduction Laboratories (Lexington, KY, USA). Antibodies to cyclin D1 and actin were purchased from PharMingen (San Diego, CA, USA) and Chemicon International Inc., respectively. Purified recombinant human soluble frizzled-related protein-1 was prepared in Dr J Rubin's laboratory as described previously (Uren et al., 2000) .
Cell proliferation was determined by a colorimetric MTT assay. Briefly, either 7.5 -10610 3 cells were dispersed in each well of a 96 well plate. Twenty-hours after culture, four different concentrations of anti-Wnt-1 or ant-Wnt-10b antibody (2 mg/ml, 0.2 mg/ml, 20 ng/ml and 2 ng/ml) were added to the cultures. The same concentrations of goat antihuman IgG (Fisher Scientific) were used as an isotype control. The antibodies were dialyzed against tissue culture medium prior to use, to remove preservatives. On 1, 2, 3, or 4 days after incubation, 20 ml of MTT solution was added to each well.
Four hours later the cells were lysed, and absorbances at 570 and 650 nM were measured and growth, as a percentage of control, was determined from the formula: % of control growth=B À AÞ=ðC À AÞ Â 100 where A=absorbance at start of incubation, B=absorbance after incubation with antibodies tested, C=absorbance after incubation with control antibody. The assays were performed in triplicate, and the results represent the mean value+ standard deviation from four independent experiments.
Flow cytometry
Cell apoptosis was assayed by propidium iodide (PI) and DIOC 6 staining, followed by flow cytometry. The HNSCC line, SNU1076, was treated with 2 mg/ml anti-Wnt-1, antiWnt-10, or control IgG for 72 h. Cells were detached from the flasks by trypsin treatment and incubated for 10 min in medium with 5 mg/ml PI and 40 nM DiOC 6 , and then were analysed by flow cytometry in a FACS caliber (BectonDickinson, San Jose, CA, USA). Viable cells had high DiOC 6 (FL-1) and low PI (FL-3) fluorescence, whereas apoptotic cells had low DiOC 6 (FL-1) and low PI (FL-3) fluorescence.
Transient luciferase assays
The pTOPFLASH-Luc reporter gene vector and the pFOPFLASH-Luc control were kindly provided by Dr Hans Clevers (University Medical Center Utrecht, The Netherlands). For TOPFLASH/FOPFLASH reporter gene assays, SNU 1076 cells were cotransfected with 0.5 mg of pTOP-FLASH-Luc or pFOPFLASH-Luc and 0.5 mg of pCMVbGal, as described previously (Korinek et al., 1997) . Cells were harvested 24 h after transfection, disrupted in lysis buffer, and luciferase and b-galactosidase activities were determined using the Dual-Light reporter gene assay system (Applied Biosystems, Foster City, CA, USA). Luciferase activities of each pTOPFLASH-Luc or pFOPFLASH-Luc transfected culture, and the b-galactosidase activities of pCMV-bGal transfected cells, were measured in the same samples using a luminometer. The transfection efficiencies of the samples were normalized by the activity of b-galactosidase.
